Total intravenous anesthesia vs single pharmacological prophylaxis to prevent postoperative vomiting in children: A

Maximilian S Schaefer1, Peter Kranke2, Stephanie Weibel2

  • 1Department of Anesthesiology, University Hospital Düsseldorf, Düsseldorf, Germany.

Paediatric Anaesthesia
|November 3, 2017
PubMed

Insights

Single pharmacological prophylaxis is as effective as total intravenous anesthesia for preventing postoperative vomiting in children. However, total intravenous anesthesia increases the risk of bradycardia during strabismus surgery.

Area of Science:

  • Anesthesiology
  • Pediatric Surgery

Background:

  • Postoperative nausea and vomiting (PONV) are common after general anesthesia in children.
  • Inhaled anesthetics can trigger PONV, leading to the use of total intravenous anesthesia (TIVA) in high-risk children.
  • The efficacy of pharmacological prophylaxis versus TIVA for preventing PONV requires investigation.

Purpose of the Study:

  • To compare the effectiveness of TIVA with single-drug pharmacological prophylaxis in preventing PONV in pediatric patients.
  • To evaluate secondary outcomes including early/late PONV, antiemetic medication needs, oral intake, PACU stay, and adverse events.

Main Methods:

  • Systematic review and meta-analysis of randomized controlled trials (RCTs) in pediatric patients (<18 years).
  • Comparison between propofol-based TIVA and inhalational anesthesia with single pharmacological prophylaxis.
  • Primary outcome: overall incidence of PONV. Secondary outcomes: early/late PONV, antiemetic use, oral intake, PACU stay, adverse events.

Main Results:

  • Four RCTs with 558 children undergoing strabismus surgery were analyzed.
  • TIVA and single pharmacological prophylaxis showed equal effectiveness in preventing overall, early, and late PONV.
  • No significant difference in the need for postoperative antiemetic medication.
  • Earlier oral intake after TIVA, but no difference in PACU stay duration.
  • Intraoperative oculocardiac reflex was more frequent with TIVA (RR 1.86 [1.01; 3.41]).

Conclusions:

  • Single pharmacological prophylaxis is as effective as TIVA for preventing PONV in pediatric patients.
  • TIVA increases the risk of bradycardia due to oculocardiac reflex during strabismus surgery.
  • Inhalational anesthesia with prophylactic antiemetics can effectively manage PONV, compensating for its emetogenic potential.
Abstract

Related Concept Videos

Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
785
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
941
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
657
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
719
General Anesthesia: Overview01:24

General Anesthesia: Overview

Anesthesia is a medical procedure that uses drugs for CNS suppression to enable painless surgeries and procedures. The selection of anesthetics is influenced by their pharmacokinetic properties, side effects, and patient characteristics. Various types of anesthesia include general, local, regional, spinal, and inhalational.
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
756
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
258